173 related articles for article (PubMed ID: 27924650)
1. Clinicopathological characteristics of biliary neuroendocrine neoplasms: a multicenter study.
Lee KJ; Cho JH; Lee SH; Lee KH; Park BK; Lee JK; Woo SM; Ryu JK; Lee JK; Kim YS; Kim JW; Lee WJ
Scand J Gastroenterol; 2017 Apr; 52(4):437-441. PubMed ID: 27924650
[TBL] [Abstract][Full Text] [Related]
2. Clinical features of 20 patients with curatively resected biliary neuroendocrine tumours.
Kim J; Lee WJ; Lee SH; Lee KB; Ryu JK; Kim YT; Kim SW; Yoon YB; Hwang JH; Han HS; Woo SM; Park SJ
Dig Liver Dis; 2011 Dec; 43(12):965-70. PubMed ID: 21856258
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological Findings and Treatment Outcomes of Patients with Primary Hepatobiliary Neuroendocrine Neoplasms: A Retrospective Single-institution Analysis.
Komiyama S; Okusaka T; Maruki Y; Ohba A; Nagashio Y; Kondo S; Hijioka S; Morizane C; Ueno H; Sukeda A; Mizui T; Takamoto T; Nara S; Ban D; Esaki M; Hiraoka N; Shimada K
Intern Med; 2024 Apr; 63(7):891-901. PubMed ID: 37612088
[TBL] [Abstract][Full Text] [Related]
4. The clinical profiles, management, and prognostic factors of biliary mixed neuroendocrine nonneuroendocrine neoplasms: A systematic review of the literature.
Wen LJ; Chen JH; Xu HJ; Yu Q; Deng Y; Liu K
Medicine (Baltimore); 2020 Dec; 99(50):e23271. PubMed ID: 33327249
[TBL] [Abstract][Full Text] [Related]
5. The clinical and prognostic factors for biliary neuroendocrine neoplasm: a study based on the SEER database.
Zheng BH; Zhang C; Wan WZ; Sun WT; Cheng X; Ni XJ; Ni XL; Suo T; Liu H; Shen S; Liu HB
BMC Surg; 2022 Jun; 22(1):253. PubMed ID: 35768809
[TBL] [Abstract][Full Text] [Related]
6. [Clinicopathological features of pancreatic neuroendocrine neoplasms: a retrospective analysis of 64 cases].
Yao W; Wang W; Li G
Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):287-93. PubMed ID: 24989916
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathological features of colorectal neuroendocrine neoplasms and prognostic significance of WHO staging system].
Zhang XH; Lu XL; Wu N; Liu B; Wang FY; Zhang RS; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):191-6. PubMed ID: 23769440
[TBL] [Abstract][Full Text] [Related]
8. Biliary Neuroendocrine Neoplasms: Clinical Profiles, Management, and Analysis of Prognostic Factors.
Zheng Z; Chen C; Li B; Liu H; Zhou L; Zhang H; Zheng C; He X; Liu W; Hong T; Zhao Y
Front Oncol; 2019; 9():38. PubMed ID: 30805307
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological characteristics of extrahepatic biliary neuroendocrine neoplasms in the gallbladder, extrahepatic biliary tract, and ampulla of Vater: A single-center cross-sectional study.
Park YM; Seo HI; Noh BG; Kim S; Hong SB; Lee NK; Kim DU; Han SY
Ann Hepatobiliary Pancreat Surg; 2023 Nov; 27(4):380-387. PubMed ID: 37840317
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine carcinoma of the ampulla of Vater: a clinicopathologic evaluation.
Selvakumar E; Rajendran S; Balachandar TG; Kannan DG; Jeswanth S; Ravichandran P; Surendran R
Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):422-5. PubMed ID: 18693180
[TBL] [Abstract][Full Text] [Related]
11. [Carcinoma of the biliary tract].
Miyazaki I; Konishi I; Nagakawa T
Gan No Rinsho; 1986 Aug; 32(10):1365-8. PubMed ID: 3783969
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Clinical Analysis of Gallbladder Neuroendocrine Neoplasms: A Large-Volume Multicenter Study During One Decade.
Wang Y; Huang B; Fu Q; Wang J; Ye M; Hu M; Qu K; Liu K; Hu X; Wei S; Sun K; Xiao W; Zhang B; Li H; Li J; Zhang Q; Liang T
Ann Surg Oncol; 2022 Nov; 29(12):7619-7630. PubMed ID: 35849293
[TBL] [Abstract][Full Text] [Related]
13. Large cell neuroendocrine carcinoma of the ampulla of Vater.
Beggs RE; Kelly ME; Eltayeb O; Crotty P; McDermott R; Ridgway PF
JOP; 2012 Sep; 13(5):470-5. PubMed ID: 22964952
[TBL] [Abstract][Full Text] [Related]
14. Biliary Neuroendocrine Neoplasms: Analysis of Prognostic Factors and Development and Validation of a Nomogram.
Zhou S; Jiang S; Chen W; Yin H; Dong L; Zhao H; Han S; He X
Front Oncol; 2021; 11():654439. PubMed ID: 34350109
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine Neoplasms of the Major Duodenal Papilla With Focus on Histopathological Features and Prognosis.
Zhang Q; Lu CJ; Zhang X; Ma Z; Xin Q; Zhang CS
Int J Surg Pathol; 2015 Sep; 23(6):433-8. PubMed ID: 25987105
[TBL] [Abstract][Full Text] [Related]
16. Biliary tract cancers in Cote-d'Or (France): incidence and natural history.
Renard P; Boutron MC; Faivre J; Milan C; Bedenne L; Hillon P; Klepping C
J Epidemiol Community Health; 1987 Dec; 41(4):344-8. PubMed ID: 3455429
[TBL] [Abstract][Full Text] [Related]
17. Tumor staging but not grading is associated with adverse clinical outcome in neuroendocrine tumors of the appendix: a retrospective clinical pathologic analysis of 138 cases.
Volante M; Daniele L; Asioli S; Cassoni P; Comino A; Coverlizza S; De Giuli P; Fava C; Manini C; Berruti A; Papotti M
Am J Surg Pathol; 2013 Apr; 37(4):606-12. PubMed ID: 23426123
[TBL] [Abstract][Full Text] [Related]
18. Surgical treatment and prognosis of gastric neuroendocrine neoplasms: a single-center experience.
Shen C; Chen H; Chen H; Yin Y; Han L; Chen J; Tang S; Yin X; Zhou Z; Zhang B; Chen Z
BMC Gastroenterol; 2016 Sep; 16(1):111. PubMed ID: 27613657
[TBL] [Abstract][Full Text] [Related]
19. Prognoses in patients with primary gastrointestinal neuroendocrine neoplasms based on the proposed new classification scheme.
Yin XN; Shen CY; Yin YQ; Chen HJ; Chen HN; Yin Y; Han LY; Chen JJ; Tang SM; Chen ZX; Zhang B
Asia Pac J Clin Oncol; 2018 Apr; 14(2):e37-e44. PubMed ID: 28856815
[TBL] [Abstract][Full Text] [Related]
20. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
